Skip to main content
. 2022 Apr 5;24(6):579–583. doi: 10.4103/aja2021132

Table 2.

Descriptive characteristics of 32 patients who underwent robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor, stratified according to experience or not a postoperative sexual impairment

Characteristics Postoperative sexual impairment: No (n=22; 68.8%) Postoperative sexual impairment: Yes (n=10; 31.3%) P
Age at surgery (year)
 Median 30 29 0.2
 Range 27–36 27–30
BMI (kg m−2)
 Median 24 24 0.4
 Range 23–26 21–25
Number of LN removed
 Median 17 16 0.9
 Range 11–21 12–19
Preoperative IIEF-5
 Median 25 25 0.7
 Range 20–25 19–25
Scholar status, n (%) 0.4
 University 7 (31.8) 5 (50.0)
 High school 10 (45.5) 5 (50.0)
 Primary school 4 (18.2) 0 (0)
 Unknown 1 (4.5) 0 (0)
Preoperative sexual impairment, n (%) 1
 No 19 (86.4) 9 (90.0)
 Yes 3 (13.6) 1 (10.0)
Preoperative RFs, n (%) 0.6
 No 5 (22.7) 4 (40.0)
 Yes 17 (77.3) 6 (60.0)
Preoperative RF categories, n (%) 0.2
 None 5 (22.7) 4 (40.0)
 Diabetes/metabolic syndrome 0 (0) 0 (0)
 Neuroleptics/antiepileptic 0 (0) 1 (10.0)
 Smoke 4 (18.2) 2 (20.0)
 Alcohol 10 (45.5) 1 (10.0)
 Smoke and alcohol 3 (13.6) 2 (20.0)
Preoperative spermiogram, n (%) 0.2
 Altered 3 (13.6) 0 (0)
 Normal 13 (59.1) 9 (90.0)
 Unknown 6 (27.3) 1 (10.0)
Type of RPLND, n (%) 0.08
 Postchemotherapy 8 (36.4) 0 (0)
 Simple 14 (63.6) 10 (100)
Year of surgery group 0.9
 2012–2016 11 (50.0) 6 (60.0)
 2017–2020 11 (50.0) 4 (40.0)
Patients’ positioning, n (%) 0.7
 Full flank 8 (36.4) 2 (20.0)
 Supine 14 (63.6) 8 (80.0)
Laterality, n (%) 0.3
 Left 7 (31.8) 6 (60.0)
 Right 15 (68.2) 4 (40.0)
Adjuvant chemotherapy, n (%) 0.8
 No 20 (90.9) 8 (80.0)
 Yes 2 (9.1) 2 (20.0)

BMI: body mass index; IIEF-5: International Index of Erectile Function-5; RPLND: retroperitoneal lymph node dissection; RFs: risk factors; LN: lymph node